In the wake of the increase in Current Liabilities in the first quarter 2021, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 564 other companies have achieved higher Quick Ratio than Cardax Inc in first quarter 2021. While Quick Ratio total ranking in the first quarter 2021 has deteriorated compared to the prior quarter from 4858 to 5465.

Explain Quick Ratio?
How much Cash & cash equivalents CDXI�s has?
What are CDXI�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CDXI Quick Ratio	(Mar 31 2021) Q1	(Dec 31 2020) Q4	(Sep 30 2020) Q3	(Jun 30 2020) Q2	(Mar 31 2020) Q1
Y / Y Current Liabilities Change	48.68 %	51.48 %	40.05 %	49.87 %	48.73 %
Y / Y Cash & cash equivalent Change	13.75 %	4.09 %	-12.87 %	-77.8 %	-71.8 %
Quick Ratio MRQ	0	0	0.01	0	0.01
CDXI's Total Ranking	# 5465	# 4858	# 5393	# 4071	# 5448
Seq. Current Liabilities Change	1.05 %	20.7 %	11.54 %	9.29 %	2.96 %
Seq. Cash & cash equivalent Change	177.46 %	-79.83 %	229.97 %	-38.42 %	153.89 %

Quick Ratio first quarter 2021 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 565
Healthcare Sector	# 1115
Overall Market	# 5465

Quick Ratio Statistics
High	Average	Low
3.47	0.24	0
(Dec 31 2013)		(Dec 31 2020)

Financial Statements
Cardax Inc 's Current Liabilities	$ 12 Millions	Visit CDXI's Balance sheet
Cardax Inc 's Cash & cash equivalent	$ 0 Millions	Visit CDXI's Balance sheet
Source of CDXI's Sales		Visit CDXI's Sales by Geography

Cumulative Cardax Inc 's Quick Ratio

CDXI's Quick Ratio for the trailling 12 Months

CDXI Quick Ratio	(Mar 31 2021) 12 Months	(Dec 31 2020) 12 Months	(Sep 30 2020) 12 Months	(Jun 30 2020) 12 Months	(Mar 31 2020) 12 Months
Y / Y Current Liabilities TTM Growth	47.58 %	47.48 %	43.89 %	46.87 %	42.19 %
Y / Y Cash & cash equivalent TTM Growth	-35.46 %	-55.15 %	-73.65 %	-76.98 %	-73.26 %
Quick Ratio TTM	0.01	0.01	0.01	0.01	0.01
Total Ranking TTM	# 4858	# 5188	# 4643	# 4738	# 4849
Seq. Current Liabilities TTM Growth	10.18 %	11.67 %	8.86 %	10.18 %	10.1 %
Seq. Cash & cash equivalent TTM Growth	3.39 %	0.4 %	-6.91 %	-33.2 %	-28.15 %

Quick ratio ranking by company, industry and sector >> Back to CDXI Financial Strength Comparisons >> Go to Compare CDXI Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q1 2021 to $12.45 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Cardax Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 516 other companies have achieved higher Quick Ratio than Cardax Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2020 from 4572 to 5107.

Explain Quick Ratio?
How much Cash & cash equivalents CDXI�s has?
What are CDXI�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 517
Healthcare Sector	# 1013
Within the Market	# 5465

trailing twelve months Quick Ratio Statistics
High	Average	Low
16.72	0.69	0
(Dec 31 2013)		(Jun 30 2020)

Companies with similar Quick Ratio in the quarter ending Mar 31 2021, within Major Pharmaceutical Preparations Industry	Quick Ratio	Mar 31 2021 MRQ Cash & cash equivalent	Mar 31 2021 MRQ Current Liabilities
Sangui Biotech International Inc	0.01	$ 0.012 Millions	$ 0.952 Millions
Actavia Life Sciences Inc	0.01	$ 0.032 Millions	$ 2.897 Millions
Provectus Biopharmaceuticals Inc	0.01	$ 0.350 Millions	$ 32.365 Millions
Innovation1 Biotech Inc	0.01	$ 0.025 Millions	$ 2.521 Millions
Novaccess Global Inc	0.01	$ 0.022 Millions	$ 2.614 Millions
Integrated Biopharma Inc	0.01	$ 0.105 Millions	$ 14.372 Millions
Ainos Inc	0.01	$ 0.009 Millions	$ 1.500 Millions
Celularity Inc	0.01	$ 0.029 Millions	$ 5.040 Millions
Cardax Inc	0.00	$ 0.062 Millions	$ 12.450 Millions
Propanc Biopharma Inc	0.00	$ 0.014 Millions	$ 3.032 Millions
Skinvisible Inc	0.00	$ 0.013 Millions	$ 2.958 Millions
Regen Biopharma Inc	0.00	$ 0.020 Millions	$ 5.249 Millions
Kaya Holdings Inc	0.00	$ 0.087 Millions	$ 25.698 Millions
Earth Science Tech Inc	0.00	$ 0.016 Millions	$ 5.091 Millions
Cannapharmarx Inc	0.00	$ 0.030 Millions	$ 14.832 Millions
Nascent Biotech Inc	0.00	$ 0.001 Millions	$ 1.224 Millions
Biostax Corp	0.00	$ 0.012 Millions	$ 10.756 Millions

Date modified: 2026-09-08T15:10:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.